期刊文献+

氟康唑立方液晶凝胶的评价 被引量:4

Quality evaluation of fluconazole-loaded cubic ohase gels
原文传递
导出
摘要 目的对氟康唑立方液晶凝胶进行表征,建立氟康唑含量测定方法。方法以甘油单油酸酯(GMO)为液晶材料制备氟康唑立方液晶凝胶,偏光显微镜及小角X衍射仪(SAXS)对氟康唑立方液晶凝胶进行表征;采用高效液相色谱法测定立方液晶凝胶中氟康唑的含量。结果立方液晶凝胶在偏光显微镜(PLM)下为暗视野;SAXS显示空白立方液晶凝胶中出现2个信号峰,分别是q1(0.832 09 nm^(-1))和q2(1.017 nm^(-1));氟康唑立方液晶凝胶中出现2个信号峰,分别是q1(0.818 88 nm^(-1))和q2(0.950 95 nm^(-1))。高效液相色谱法测定立方液晶凝胶中氟康唑在20~500μg/ml范围内线性关系良好。结论 PLM及SAXS适宜于立方液晶凝胶表征,高效液相测定方法可用于氟康唑立方液晶凝胶的质量控制和评价。 Objective To characterize the internal structures of fluconazole-loaded cubic phase gels and establish a method for determination of fluconazole. Methods Glycerol monooleate( GMO) was used as the liquid crystal material to prepare the fluconazole loaded cubic phase gels. Polarizing light microscopy( PLM) and small-angle X-ray scattering( SAXS) were used to confirm their internal structures and establish an HPLC method for determination of their content.Results Cubic phase gels were the dark field under PLM,SAXS showed that the blank cubic phase gels had two single peaks: q1( 0. 832 09 nm^(-1)) and q2( 1. 017 nm^(-1)) while the fluconazole-loaded cubic phase gels had two single peaks:q1( 0. 818 88 nm^(-1)) and q2( 0. 950 95 nm^(-1)). Under the selected HPLC,the linearity within the range of 20- 500 μg/ml was good. Conclusion PLM and SAXS are reliable for characterization of cubic phase gels. The HPLC method can be used in quality control and evaluation of this enema.
出处 《军事医学》 CAS CSCD 北大核心 2015年第12期948-951,共4页 Military Medical Sciences
关键词 氟康唑 立方液晶凝胶 显微镜检查 偏振 小角X衍射仪 色谱法 高效液相 fluconazole cubic phase gels microscopy polarization SAXS chromatography high pressure liquid
  • 相关文献

参考文献3

二级参考文献64

  • 1王志宁,郑利强,李干佐.蔗糖对MO/水立方液晶体系流变性质的影响[J].化学学报,2005,63(4):274-278. 被引量:15
  • 2水玲玲,王志宁,郑利强.Rheological Properties of Cubic Liquid Crystals Formed from Monoglyceride/H2O Systems[J].Chinese Journal of Chemistry,2005,23(3):245-250. 被引量:1
  • 3Waterbury L, Kunysz EA, Bewerman R. Effect of steroidal and non steroidal anti-inflammatory agents on corneal wound healing. J Ocul Pharmacol 1987; 3: 43-54.
  • 4Schalnus R. Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica 2003; 217: 89-98.
  • 5Joseph TM. A critical look at ocular allergy drugs. Am Fam Physician 1996; 53: 2637-42.
  • 6Stroobants A, Fabre K, Maudgal PC. Effect of non-steroidal antiinflammatory drugs (NSAID) on the rabbit corneal epithelium studied by scanning electron microscopy. Bull Soc Beige Ophtalmol 2000; 276: 73-81.
  • 7Araujo J, Vega E, Lopes C, Egea MA, Garcia ML, Souto EB. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-toaded PLGA nanospheres. Colloid Surfaces B 2009; 72: 48- 56,.
  • 8Label information of Ocufen. Label approved on 08/25/2003. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ la bel/2003/19404scp020_ocufen_lbl.pdf.
  • 9Ahuja M, DhakeAS, Sharma SK, Majumdar DK. Topical ocular delivery of NSAIDs. AAPS J 2008; 10: 229-41.
  • 10Li N, Zhuang CY, Wang M, Sun XY, Nie SF, Pan WS. Liposome coated with tow molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 2009; 379: 131-8.

共引文献22

同被引文献28

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部